
ROP linked to low haemoglobin
A retrospective study of 385 infants born at a mean gestational age of 26.4 weeks has shown that early, low-foetal haemoglobin (HbF) is associated with abnormal retinal neurovascular

A retrospective study of 385 infants born at a mean gestational age of 26.4 weeks has shown that early, low-foetal haemoglobin (HbF) is associated with abnormal retinal neurovascular

A three-year clinical trial of enteral supplementation with fatty acids in premature infants has demonstrated a lowering of the risk of severe retinopathy of prematurity (ROP) by 50%. Three

Following Glaukos’ acquisition of Avedro in 2019, the company is poised to introduce a range of new corneal health products into the Australian and New Zealand markets to complement its

EviRed, a new artificial intelligence algorithm, is being ‘trained’ to predict the risk of diabetic retinopathy (DR) using modern imaging techniques. Professor Ramin Tadayoni at the University of

Glaukos has appointed Neville White as regional business manager to support the rollout of its new corneal health business in Australasia. A former orthoptist in a busy ophthalmic practice in

A study of 6,398 Covid-19-infected patients has shown that those with age-related macular degeneration (AMD) declined more rapidly, died at three times the rate of patients without AMD, and one in

After the turbulent times of 2020, causing the postponement of the 2020 RANZCO NZ Branch Annual Scientific Meeting to 19-20 March this year, the NZ Branch executive is determined the 2021 meeting will proceed regardless of Covid-19 alert levels. To achieve this, a hybrid meeting system has been adop

On behalf of the organising committee, I am pleased to invite and welcome you to the 2021 RANZCO New Zealand Branch Annual Scientific Meeting and the New Zealand Ophthalmic Nurses Group Meeting.

Exonate has begun a 48-patient clinical trial of its EXN407 drops for diabetic macular oedema (DMO), hoping they will eventually supplant intravitreal anti-vascular endothelial growth factor (VEGF) therapy injections.

Australian adults and parents of children with inherited retinal diseases (IRDs) are being asked to contribute their views to a new research survey on emerging gene therapies.

Dr Kaliopy Matheos has joined the Eye Institute team in Auckland. A New Zealand-trained ophthalmologist, Dr Matheos was awarded the Arthur Thomas Paterson Scholarship from the University of Auckland

Lenovo has introduced new smart glasses, Think Reality A3, offering productivity boosting technology to enable smarter workers in businesses big and small. “The A3 is a next generation augmented